Kidney Stone Management Market Overview
The global kidney stone management market is witnessing a steady surge, driven by technological advancements, increased prevalence of kidney stones, and a growing shift toward minimally invasive procedures. According to the latest market analysis, the kidney stone management market size was valued at USD 2.57 billion in 2024 and is projected to reach USD 3.84 billion by 2032, expanding at a compound annual growth rate (CAGR) of 5.14% during the forecast period from 2025 to 2032.
Growth Drivers:
The primary driver of growth in the kidney stone management industry is the rising adoption of minimally invasive urological procedures. These techniques, including ureteroscopy, extracorporeal shock wave lithotripsy (ESWL), and percutaneous nephrolithotomy (PCNL), offer patients faster recovery, lower complication rates, and improved outcomes. Advancements in laser technologies, such as the MOSES platform by Lumenis, have further improved precision and efficiency in kidney stone fragmentation, minimizing tissue damage and enhancing patient care.
Get a Free Sample Report of Kidney Stone Management Market@ https://www.snsinsider.com/sample-request/7372
An increasing prevalence of kidney stones, particularly calcium oxalate and uric acid stones, due to dietary habits, sedentary lifestyles, and obesity, has contributed to the market’s upward trajectory. According to clinical data, nearly 10% of adults in the United States are affected by kidney stones at some point in their lives. As a result, the need for rapid, accurate diagnosis and treatment options is growing exponentially.
Moreover, the transition from inpatient to outpatient procedures and a growing number of ambulatory surgical centers have opened new avenues for kidney stone treatment in non-hospital settings. This structural shift is being further supported by favorable reimbursement policies, rising healthcare expenditures, and increasing investments in advanced medical technologies globally.
Kidney Stone Management Market Segmentation by Type
In 2024, the ureteroscopy segment dominated the kidney stone management market, holding 51% of the total market share. This dominance is fueled by the widespread use of minimally invasive surgeries, which offer shorter hospital stays, quicker recovery periods, and reduced chances of recurrence. Technological enhancements in ureteroscopy—especially in lithotripsy and high-resolution imaging—have transformed it into the preferred treatment method among both clinicians and patients.
Innovations such as single-use flexible ureteroscopes and high-powered lasers (e.g., holmium and MOSES) have significantly increased procedural efficiency and safety. For instance, Lumenis’ MOSES technology, introduced in March 2020, enables the fragmentation of stones with reduced thermal damage to surrounding tissues. Regulatory endorsements from authorities like the European Association of Urology, recommending flexible ureteroscopic lithotripsy as the first-line treatment for stones smaller than 2cm, further validate the segment’s credibility and projected growth.
Kidney Stone Management Market Segmentation by End User
Hospitals emerged as the dominant end users in 2024, driven by their ability to handle complex cases and offer a full spectrum of care. With comprehensive imaging capabilities, surgical proficiency, and access to the latest equipment, hospitals remain the primary centers for procedures such as ESWL, PCNL, and advanced endourology. Moreover, robust reimbursement mechanisms and large-scale investment in urology technologies ensure hospitals maintain a central role in kidney stone treatment.
However, specialty clinics are expected to witness the fastest growth rate through 2032. These facilities are benefiting from shorter patient wait times, streamlined care pathways, and early adoption of new technologies like single-use ureteroscopes and novel lithotripsy devices. The increasing number of ambulatory surgical centers offering efficient outpatient care is transforming how patients access kidney stone management services. In the UK, for example, the National Health Service (NHS) recorded a 12% year-on-year increase in ureteroscopy procedures between 2023 and 2024, underscoring the shift toward minimally invasive, clinic-based interventions.
Kidney Stone Management Market Regional Insights
North America led the global kidney stone management market in 2024, accounting for nearly 37% of the market share. With an estimated valuation of USD 0.75 billion in 2024, the U.S. market is expected to reach USD 1.11 billion by 2034, driven by a robust healthcare infrastructure, high prevalence of kidney stones, and proactive adoption of cutting-edge technologies.
The region’s leadership is supported by favorable reimbursement models, well-established urology departments, and widespread access to specialized care. Hospitals and surgical centers in North America are quick to adopt technologies such as robotic-assisted urology procedures and laser lithotripsy systems, accelerating the standard of care in kidney stone treatment.
Europe Holds Second Position
Europe represents the second-largest regional market, driven by growing awareness, lifestyle-related kidney stone risk factors, and governmental support for healthcare modernization. Countries like Germany, France, and the United Kingdom lead in terms of both adoption of advanced treatments and infrastructure investments. High acceptance of non-invasive treatment methods and established reimbursement policies enable broader access to high-end kidney stone management services across the continent.
Investments in research and development continue to push the boundaries in imaging and stone-removal technologies, while an aging population and increasing obesity rates create persistent demand for effective solutions.
Asia-Pacific: Fastest-Growing Region
The Asia-Pacific kidney stone management market is set to expand at the fastest pace during the forecast period. Countries such as China, India, and Japan are witnessing increased incidences of kidney stones due to lifestyle changes and rising awareness. This regional boom is underpinned by government healthcare initiatives, improving economic conditions, and expanding access to modern urological care.
Asia-Pacific presents a significant opportunity for companies focusing on urinary stone management, especially given the low penetration of advanced technologies. Ongoing educational campaigns, increasing disposable income, and expanding insurance coverage further support the rapid adoption of procedures like ESWL, ureteroscopy, and PCNL.
Need Any Customization Research on Kidney Stone Management Market, Enquire Now@ https://www.snsinsider.com/enquiry/7372
Key Companies in the Kidney Stone Management Market
The kidney stone management landscape is characterized by intense innovation and competitive activity. Key players include Olympus Corp., Storz Medical AG, Medi Spec Ltd., Cook Medical Inc., Richard Wolf GmbH, Lumenis, EDAP TMS, DirexGroup, Elmed Electronics & Medical Industry & Trade Inc., Convergent Laser Technologies, E.M.S. Electro Medical Systems S.A., and C.R. Bard Inc. These companies are continuously advancing their product portfolios, with a focus on disposable devices, laser lithotripsy systems, and endoscopic visualization tools.
Strategic partnerships, technological collaborations, and geographical expansion are common tactics used by these players to maintain their market presence and explore emerging opportunities, particularly in fast-developing regions such as Asia-Pacific and Latin America.
Read Our Other Report
Radiopharmaceutical Injectors Market
About Us:
SNS Insider is one of the leading market research and consulting agencies that dominates the market research industry globally. Our company’s aim is to give clients the knowledge they require in order to function in changing circumstances. In order to give you current, accurate market data, consumer insights, and opinions so that you can make decisions with confidence, we employ a variety of techniques, including surveys, video talks, and focus groups around the world.
Contact Us:
Jagney Dave – Vice President of Client Engagement
Phone: +1-315 636 4242 (US) | +44- 20 3290 5010 (UK)
Email: [email protected]
